Maternal Plasma Procalcitonin Levels in Pregnancy with Premature Rupture of Membranes
Author Information
Author(s): Andrzej Torbé
Primary Institution: Pomeranian Medical University
Hypothesis
Are maternal plasma procalcitonin concentrations useful in diagnosing preterm premature rupture of membranes and predicting delivery intervals?
Conclusion
Maternal plasma procalcitonin levels are elevated in pregnancies with premature rupture of membranes but do not effectively diagnose infections or predict delivery intervals.
Supporting Evidence
- Procalcitonin levels were significantly higher in women with pPROM and PROM at term compared to healthy controls.
- No significant correlation was found between procalcitonin levels and laboratory indices of infection.
- The study found that procalcitonin levels did not effectively predict neonatal infections or delivery intervals.
Takeaway
The study looked at a blood marker called procalcitonin in pregnant women with water breaking early. It found that while the levels were higher in these women, they didn't help much in figuring out if there was an infection or when the baby would be born.
Methodology
The study involved 142 women divided into four groups based on their pregnancy conditions, with blood samples taken to measure procalcitonin levels and other laboratory indices.
Limitations
The predictive values of procalcitonin for diagnosing infections and predicting delivery intervals were poor.
Participant Demographics
Participants included women with preterm premature rupture of membranes, term premature rupture of membranes, and healthy pregnant women at different gestational ages.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website